Variant report
Variant | nsv884079 |
---|---|
Chromosome Location | chr6:30435288-30447987 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:30)
- CpG islands (count:61)
- Chromatin interactive region (count:10)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:30 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr6:30438818-30439151 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr6:30438803-30439128 | HepG2 | liver: | n/a | chr6:30439061-30439074 chr6:30438959-30438970 |
3 | CEBPB | chr6:30438786-30439148 | K562 | blood: | n/a | chr6:30439061-30439074 chr6:30438959-30438970 |
4 | CEBPB | chr6:30438777-30439163 | Hela-S3 | cervix: | n/a | chr6:30439061-30439074 chr6:30438959-30438970 |
5 | CEBPB | chr6:30438794-30439097 | A549 | lung: | n/a | chr6:30439061-30439074 chr6:30438959-30438970 |
6 | CEBPB | chr6:30438765-30439122 | K562 | blood: | n/a | chr6:30439061-30439074 chr6:30438959-30438970 |
7 | CEBPB | chr6:30438805-30439103 | H1-hESC | embryonic stem cell: | n/a | chr6:30439061-30439074 chr6:30438959-30438970 |
8 | CEBPB | chr6:30438780-30439151 | IMR90 | lung: | n/a | chr6:30439061-30439074 chr6:30438959-30438970 |
9 | CTCF | chr6:30439665-30439743 | Kidney_OC | kidney: | n/a | n/a |
10 | EP300 | chr6:30438808-30439053 | Hela-S3 | cervix: | n/a | chr6:30438960-30438974 |
11 | EP300 | chr6:30438886-30439072 | K562 | blood: | n/a | chr6:30438960-30438974 chr6:30439050-30439060 |
12 | FAM48A | chr6:30447891-30447964 | GM12878 | blood: | n/a | n/a |
13 | FOS | chr6:30447832-30448128 | MCF10A-Er-Src | breast: | n/a | chr6:30447979-30447988 |
14 | FOS | chr6:30447811-30448127 | MCF10A-Er-Src | breast: | n/a | chr6:30447979-30447988 |
15 | FOS | chr6:30447815-30448125 | MCF10A-Er-Src | breast: | n/a | chr6:30447979-30447988 |
16 | FOS | chr6:30447837-30448073 | MCF10A-Er-Src | breast: | n/a | chr6:30447979-30447988 |
17 | JUN | chr6:30438794-30439088 | HepG2 | liver: | n/a | chr6:30438960-30438973 |
18 | JUN | chr6:30447972-30447995 | H1-hESC | embryonic stem cell: | n/a | chr6:30447979-30447988 |
19 | JUND | chr6:30438844-30439033 | K562 | blood: | n/a | n/a |
20 | JUND | chr6:30447932-30448040 | HepG2 | liver: | n/a | chr6:30447979-30447988 chr6:30447977-30447988 |
21 | JUND | chr6:30438834-30439096 | HepG2 | liver: | n/a | n/a |
22 | MYC | chr6:30447979-30448086 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | MYC | chr6:30438881-30438931 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | NR2F2 | chr6:30443290-30443770 | K562 | blood: | n/a | n/a |
25 | NR2F2 | chr6:30443387-30443754 | K562 | blood: | n/a | n/a |
26 | PAX5 | chr6:30442332-30442564 | GM12878 | blood: | n/a | n/a |
27 | POLR2A | chr6:30436614-30436773 | ProgFib | skin: | n/a | n/a |
28 | POLR2A | chr6:30440194-30440304 | ProgFib | skin: | n/a | n/a |
29 | STAT3 | chr6:30447901-30448022 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | ZNF263 | chr6:30435081-30435395 | HEK293-T-REx | kidney: | n/a | chr6:30435186-30435207 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:30437493-30437543 | HNPCEpiC | eye: | n/a |
2 | chr6:30437493-30437543 | H1-hESC | embryonic stem cell: | embryo |
3 | chr6:30437493-30437543 | A549 | lung: | n/a |
4 | chr6:30437493-30437543 | IMR90 | lung: | fetal |
5 | chr6:30437493-30437543 | AG10803 | skin: | n/a |
6 | chr6:30437493-30437543 | AG09319 | gingival: | n/a |
7 | chr6:30437493-30437543 | MCF-7 | breast: | n/a |
8 | chr6:30437493-30437543 | RPTEC | kidney: | n/a |
9 | chr6:30437493-30437543 | U87 | brain: | n/a |
10 | chr6:30437493-30437543 | MCF10A-Er-Src | breast: | n/a |
11 | chr6:30437493-30437543 | SK-N-SH_RA | brain: | n/a |
12 | chr6:30437493-30437543 | AG09309 | skin: | n/a |
13 | chr6:30437493-30437543 | HRCEpiC | kidney: | n/a |
14 | chr6:30437493-30437543 | HPAEpiC | pulmonary alveolar: | n/a |
15 | chr6:30437493-30437543 | Caco-2 | colon: | n/a |
16 | chr6:30437493-30437543 | HCT-116 | colon: | n/a |
17 | chr6:30437493-30437543 | NT2-D1 | testis: | n/a |
18 | chr6:30437493-30437543 | PrEC | prostate: | n/a |
19 | chr6:30437493-30437543 | K562 | blood: | n/a |
20 | chr6:30437493-30437543 | SK-N-MC | brain: | n/a |
21 | chr6:30437493-30437543 | BE2_C | brain: | n/a |
22 | chr6:30437493-30437543 | ProgFib | skin: | n/a |
23 | chr6:30437493-30437543 | AoSMC | blood vessel: | n/a |
24 | chr6:30437493-30437543 | SKMC | muscle: | n/a |
25 | chr6:30437493-30437543 | HRPEpiC | eye: | n/a |
26 | chr6:30437493-30437543 | GM12878 | blood: | n/a |
27 | chr6:30437493-30437543 | ovcar-3 | ovarian: | n/a |
28 | chr6:30437493-30437543 | HepG2 | liver: | n/a |
29 | chr6:30437493-30437543 | LNCaP | prostate: | n/a |
30 | chr6:30437493-30437543 | HL-60 | blood: | n/a |
31 | chr6:30437493-30437543 | Jurkat | blood: | n/a |
32 | chr6:30437493-30437543 | HUVEC | blood vessel: | n/a |
33 | chr6:30437493-30437543 | GM06990 | blood: | n/a |
34 | chr6:30437493-30437543 | ECC-1 | luminal epithelium: | n/a |
35 | chr6:30437493-30437543 | HCF | heart: | n/a |
36 | chr6:30437493-30437543 | HIPEpiC | eye: | n/a |
37 | chr6:30437493-30437543 | GM12891 | blood: | n/a |
38 | chr6:30437493-30437543 | T-47D | breast: | n/a |
39 | chr6:30437493-30437543 | AG04449 | skin: | fetal |
40 | chr6:30437493-30437543 | PFSK-1 | brain: | n/a |
41 | chr6:30437493-30437543 | BJ | skin: | n/a |
42 | chr6:30437493-30437543 | HEK293 | kidney: | embryo |
43 | chr6:30437493-30437543 | CMK | blood: | n/a |
44 | chr6:30437493-30437543 | SK-N-SH | brain: | n/a |
45 | chr6:30437493-30437543 | NHDF-neo | bronchial: | n/a |
46 | chr6:30437493-30437543 | HRE | kidney: | n/a |
47 | chr6:30437493-30437543 | GM12892 | blood: | n/a |
48 | chr6:30437493-30437543 | NH-A | brain: | n/a |
49 | chr6:30437493-30437543 | NHBE | bronchial: | n/a |
50 | chr6:30437493-30437543 | GM19239 | blood: | n/a |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:30447631..30450065-chr6:30691817..30695001,3 | K562 | blood: | |
2 | chr6:30447476..30449412-chr6:30509865..30511998,2 | K562 | blood: | |
3 | chr6:30433130..30435301-chr6:30582917..30586018,4 | MCF-7 | breast: | |
4 | chr6:30431634..30435485-chr6:30582972..30586314,3 | K562 | blood: | |
5 | chr6:30428958..30430493-chr6:30439620..30441525,2 | MCF-7 | breast: | |
6 | chr6:30447949..30451648-chr6:30569801..30572499,4 | MCF-7 | breast: | |
7 | chr6:30446384..30451689-chr6:30578094..30585004,12 | MCF-7 | breast: | |
8 | chr6:30446515..30448275-chr6:30457111..30458820,2 | K562 | blood: | |
9 | chr6:30446309..30448997-chr6:30451629..30454419,2 | MCF-7 | breast: | |
10 | chr6:30447797..30449612-chr6:30512660..30515323,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SUCLA2P1 | TF binding region |
SUCLA2P1 | CpG island |
ENSG00000204569 | chromatin interactions |
ENSG00000204592 | chromatin interactions |
ENSG00000222894 | chromatin interactions |
ENSG00000204568 | chromatin interactions |
ENSG00000236603 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6930977 | chr6:30435288-30435289 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs568284987 | chr6:30435398-30435399 | Bivalent Enhancer Enhancers Bivalent/Poised TSS | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs556684427 | chr6:30435443-30435444 | Bivalent Enhancer Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs142300195 | chr6:30435453-30435454 | Bivalent Enhancer Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs542216840 | chr6:30435458-30435459 | Bivalent Enhancer Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs559315383 | chr6:30435470-30435471 | Bivalent Enhancer Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs557751463 | chr6:30435509-30435510 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555047141 | chr6:30435562-30435563 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527957962 | chr6:30435621-30435622 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546665058 | chr6:30435631-30435632 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375920180 | chr6:30435674-30435675 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs147905164 | chr6:30435751-30435752 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533614315 | chr6:30435776-30435777 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191810662 | chr6:30435778-30435779 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2516669 | chr6:30435801-30435802 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs560380794 | chr6:30435862-30435863 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547616599 | chr6:30435873-30435874 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115794740 | chr6:30435878-30435879 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12214645 | chr6:30435930-30435931 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs115164168 | chr6:30435945-30435946 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs115787549 | chr6:30446493-30446494 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs554003434 | chr6:30446521-30446522 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs368890174 | chr6:30446522-30446523 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs545983615 | chr6:30446526-30446527 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs562404762 | chr6:30446540-30446541 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs117142007 | chr6:30446560-30446561 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs115101222 | chr6:30446570-30446571 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs561375615 | chr6:30446578-30446579 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs368392469 | chr6:30446590-30446591 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs375640348 | chr6:30446616-30446617 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs530319759 | chr6:30446641-30446642 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs546935541 | chr6:30446659-30446660 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs190004112 | chr6:30446682-30446683 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs532556264 | chr6:30446769-30446770 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs181202343 | chr6:30446821-30446822 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs569223210 | chr6:30446869-30446870 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs74223639 | chr6:30446871-30446872 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs554653259 | chr6:30446882-30446883 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs7775268 | chr6:30446963-30446964 | Inactive region | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs115453734 | chr6:30447010-30447011 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs375594581 | chr6:30447019-30447020 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs373909357 | chr6:30447024-30447025 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs186405738 | chr6:30447133-30447134 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs560421333 | chr6:30447189-30447190 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs547172047 | chr6:30447208-30447209 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs143146114 | chr6:30447240-30447241 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs565707854 | chr6:30447297-30447298 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs545647081 | chr6:30447305-30447306 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs556345645 | chr6:30447309-30447310 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs200082139 | chr6:30447345-30447346 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 21569311 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:30434600-30435400 | Bivalent Enhancer | Primary T helper memory cells from peripheral blood 2 | blood |
2 | chr6:30434800-30435400 | Bivalent Enhancer | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr6:30434800-30435400 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
4 | chr6:30434800-30435400 | Bivalent Enhancer | Primary T helper memory cells from peripheral blood 1 | blood |
5 | chr6:30434800-30435400 | Bivalent Enhancer | Primary T killer naive cells fromperipheralblood | blood |
6 | chr6:30434800-30435400 | Bivalent Enhancer | Rectal Mucosa Donor 31 | rectum |
7 | chr6:30434800-30435600 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
8 | chr6:30434800-30435600 | Bivalent Enhancer | Primary T helper cells PMA-I stimulated | -- |
9 | chr6:30434800-30435600 | Bivalent Enhancer | Primary T helper 17 cells PMA-I stimulated | -- |
10 | chr6:30434800-30435600 | Bivalent Enhancer | Primary T cells effector/memory enriched fromperipheralblood | blood |
11 | chr6:30434800-30435600 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
12 | chr6:30434800-30435600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr6:30435000-30435400 | Bivalent Enhancer | Primary T cells from cord blood | blood |
14 | chr6:30435000-30435400 | Bivalent Enhancer | Primary T helper cells fromperipheralblood | blood |
15 | chr6:30435000-30435400 | Bivalent Enhancer | Primary T regulatory cells fromperipheralblood | blood |
16 | chr6:30435200-30435400 | Bivalent Enhancer | ES-I3 Cell Line | embryonic stem cell |
17 | chr6:30435200-30435400 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
18 | chr6:30435200-30435400 | Bivalent Enhancer | Primary T helper naive cells from peripheral blood | blood |
19 | chr6:30435200-30435400 | Bivalent/Poised TSS | Skeletal Muscle Male | skeletal muscle |
20 | chr6:30435200-30435600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin03 | Skin |
21 | chr6:30435200-30435600 | Bivalent Enhancer | Colonic Mucosa | Colon |
22 | chr6:30435200-30436000 | Bivalent Enhancer | Primary T helper naive cells fromperipheralblood | blood |
23 | chr6:30447800-30448200 | Bivalent Enhancer | Primary T helper 17 cells PMA-I stimulated | -- |
24 | chr6:30447800-30448400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
25 | chr6:30447800-30450200 | Bivalent Enhancer | Primary T helper memory cells from peripheral blood 1 | blood |